PCLO PharmaCielo Ltd.
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. It offers medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About PharmaCielo (CVE: PCLO)
›
PharmaCielo (CVE: PCLO) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.
The shares were at 0.0350 CAD on 20 November 2026, down 22.2% over 52 weeks. Its 52-week range is 0.0350 CAD to 0.1650 CAD, and it trades at the bottom of that range.
Its market capitalisation is 7.74M CAD.
PharmaCielo reports return on equity of 32.6%, an operating margin of -86.7% and revenue up 331.0% year over year.
Its debt exceeds its cash by 18.14M CAD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 26 November 2026.